Roche secures CE mark for ovarian cancer detection test
The CE mark for the assay follows earlier pre-authorisation in Austria and Germany.
Therapy Area
The Trump presidency and its potential impact on reproductive health
Abbott’s Amplatzer Amulet shows promise in atrial fibrillation trial
Mursla Bio’s EvoLiver blood test shows promise in HCC surveillance
BrightHeart receives 510(k) clearance from FDA for prenatal ultrasound software
How decentralisation can fill the gaps in Alzheimer’s research
Boston Scientific reports outcomes from trial of LAAC device
GE HealthCare’s SIGNA MAGNUS MRI scanner gains FDA clearance
